Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12185-020-02856-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
JSH practical guidelines for hematological malignancies, 2023: leukemia-6. Myelodysplastic syndromes (MDS).
Int J Hematol
January 2025
Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Correction: JSH practical guidelines for hematological malignancies, 2023: leukemia-2-acute promyelocytic leukemia (APL).
Int J Hematol
December 2024
Department of Hematology, Saiseikai Yokohama Nanbu Hospital, 3-2-10 Konandai, Konan-ku, Yokohama, Kanagawa, 234-0054, Japan.
Correction: JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML).
Int J Hematol
December 2024
Department of Hematology and Oncology, Okayama University Hospital, 2-5-1 Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).
Int J Hematol
January 2025
Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake-cho, Miyazaki City, Miyazaki, 889-1692, Japan.
Developing an Individualized Patient Decision Aid for Chronic Coronary Disease Based on the ISCHEMIA Trial: A Mixed-Methods Study.
Circ Cardiovasc Qual Outcomes
October 2024
University of Missouri-Kansas City School of Medicine (D.D.N., S.L.F., N.I., A.I.U., J.A.S.).
Article Synopsis
- The study aimed to create a patient decision aid (PDA) to help patients with chronic coronary disease (CCD) understand their options for invasive vs. conservative management, drawing on data from the ISCHEMIA trial.
- Through focus groups with patients, caregivers, and healthcare professionals, researchers identified key patient priorities, emphasizing the importance of survival and quality of life in treatment decisions, as well as a preference for visual tools to illustrate outcomes.
- Participants valued shared decision-making but often relied on clinicians for guidance, expressing a desire to use the PDA collaboratively during consultations to facilitate informed choices.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!